Nuvectis Pharma Inc. (NVCT)

AI Score

Unlock

8.34

0.09 (1.09%)

At close: Apr 07, 2025, 3:59 PM

8.24

-1.20%

After-hours: Apr 07, 2025, 04:05 PM EDT

Nuvectis Pharma Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Chart Mode

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	18.53M	17.17M	18.12M	19.46M	19.13M	22.06M	24.6M	15.47M	19.99M	23.64M	13.57M	16.69M	5.74M	6.81M	7.21M	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	824K	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	74K	138K	182K	250K	59K	203K	341K	740K	412K	1.23M	666K	925K	91K	n/a	n/a	n/a
Total Current Assets	18.61M	17.31M	18.3M	19.71M	19.18M	22.26M	24.94M	16.21M	20.41M	24.87M	14.24M	17.62M	5.83M	6.81M	7.21M	n/a
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	824K	n/a	n/a	n/a
Total Assets	18.61M	17.31M	18.3M	19.71M	19.18M	22.26M	24.94M	16.21M	20.41M	24.87M	14.24M	17.62M	6.66M	6.81M	7.21M	n/a
Account Payables	2.5M	2.26M	1.85M	1.76M	2.77M	3.49M	1.8M	2.1M	2.91M	2.25M	1.43M	1.35M	1.06M	495K	389K	33K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	5.56M	4.05M	n/a	n/a	n/a	n/a	399K	n/a	450K	640K	341K	921K	824K	n/a	n/a	n/a
Total Current Liabilities	8.89M	6.32M	5.77M	5.69M	6.98M	5.58M	4.61M	3.93M	6.19M	4.49M	2.74M	3.06M	2.42M	495K	389K	33K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	15.25M	11.22M	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.1M	2.91M	n/a	1.43M	1.35M	15.25M	15.25M	11.22M	n/a
Total Liabilities	8.89M	6.32M	5.77M	5.69M	6.98M	5.58M	4.61M	3.93M	6.19M	4.49M	2.74M	3.06M	17.66M	15.74M	11.61M	33K
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	n/a	n/a	18.65B	n/a	17.77B	17.33B	17.23B	n/a	n/a	n/a	n/a	0.00	n/a	n/a	n/a	n/a
Retained Earnings	-73.25M	-67M	-62.84M	-58.42M	-54.24M	-47.62M	-41.74M	-36.03M	-31.98M	-25.29M	-19.41M	-15.84M	-12.9M	-10.64M	-5.97M	-33K
Comprehensive Income	n/a	n/a	n/a	-0.00	n/a	n/a	n/a	n/a	n/a	0.00	n/a	-0.00	0.00	-0.00	n/a	n/a
Shareholders Equity	9.71M	10.99M	12.53M	14.02M	12.2M	16.69M	20.33M	12.27M	14.22M	20.37M	11.5M	14.56M	-11.01M	-8.93M	-4.4M	-33K
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a